Dr Tue H. Nguyen is currently an independent Pharmaceutical Biotech consultant.
From 2006 to 2012 Dr Nguyen served as Vice President, Chemistry and Manufacturing, then Vice president, Research and Pre-clinical Development, at the Institute for One World Health (OWH), a non-profit pharmaceutical company in San Francisco. He was responsible for directing R&D activities at OWH focusing on expanding the Diarrhea portfolio of projects, and leading the development of CFTR inhibitor as a treatment for acute secretory diarrhea. He was also Project Team Leader of the semi-synthetic artemisinin project, developing a new production technology based on synthetic biology and photochemistry to manufacture the key ingredient in the treatment of Malaria.
Before joining OWH, he spent over twenty years at Genentech, a biotech pharmaceutical company in South San Francisco, progressing from scientist to Director of Pharmaceutical Research and Development where he was in charge of all product pre-formulation, formulation and drug delivery system development. He also served as Director, Analytical Sciences responsible for protein structure and activity characterization, as well as bio-analytical assays development for preclinical and clinical studies.
Dr Nguyen received his BS in Pharmacy from the School of Pharmacy, University of Saigon, VN, his MS in Industrial Pharmacy from St John University, New York, USA, and his PhD in Pharmaceutical Chemistry from the University of Kansas, USA. He is a Fellow of the American Association of Pharmaceutical Scientists. He was a member of the Board of Industrial Advisor for the Higuchi Bioscience Center, Kansas University, and adjunct associate professor at the Kansas University School of Pharmacy. He has also served as a member of the Pharmaceutical Development Steering Committee of PhRMA, the Pharmaceutical Manufacturer Association
Back to List | Back to Top